abstract |
Human growth hormone variants are disclosed having enhancednaffinity for the growth hormone receptor. Also disclosednare human growth hormone variants conjugated to one or morenchemical groups, such as poly(ethylene glycol), which isnbelieved to prolong the in vivo half-life of the variants. |